Cargando…

Cost-Effectiveness Study of Three Antimalarial Drug Combinations in Tanzania

BACKGROUND: As a result of rising levels of drug resistance to conventional monotherapy, the World Health Organization (WHO) and other international organisations have recommended that malaria endemic countries move to combination therapy, ideally with artemisinin-based combinations (ACTs). Cost is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiseman, Virginia, Kim, Michelle, Mutabingwa, Theonest K, Whitty, Christopher J. M
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592341/ https://www.ncbi.nlm.nih.gov/pubmed/17032059 http://dx.doi.org/10.1371/journal.pmed.0030373

Ejemplares similares

Randomized Trial of Artesunate+Amodiaquine, Sulfadoxine-Pyrimethamine+Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania
por: Mutabingwa, Theonest K., et al.
Publicado: (2009)

Rolling Back a Malaria Epidemic in South Africa
por: Duffy, Patrick E, et al.
Publicado: (2005)

Combination of probenecid-sulphadoxine-pyrimethamine for intermittent preventive treatment in pregnancy
por: Gutman, Julie, et al.
Publicado: (2012)

Red cell distribution width and preeclampsia: a systematic review and meta-analysis
por: Adam, Ishag, et al.
Publicado: (2019)

Predictors of residual antimalarial drugs in the blood in community surveys in Tanzania
por: Gallay, Joanna, et al.
Publicado: (2018)

Hypertension and Maternal–Fetal Conflict during Placental Malaria
por: Muehlenbachs, Atis, et al.
Publicado: (2006)

Environmentally Responsible and Cost-Effective Synthesis of the Antimalarial Drug Pyronaridine
por: Kincaid, Joseph R. A., et al.
Publicado: (2022)

Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa
por: O’Boyle, Shennae, et al.
Publicado: (2020)

Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities
por: Whitty, Christopher JM, et al.
Publicado: (2008)

Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa
por: Ochong, Edwin, et al.
Publicado: (2003)

Quantifying the pharmacology of antimalarial drug combination therapy
por: Hastings, Ian M., et al.
Publicado: (2016)

Study of possibility physical interactions antimalarial combination drugs
por: Simorangkir, Timbul Partogi H.
Publicado: (2020)

Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria
por: Kabyemela, Edward R, et al.
Publicado: (2008)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

A Nationwide Survey of the Quality of Antimalarials in Retail Outlets in Tanzania
por: Kaur, Harparkash, et al.
Publicado: (2008)

Plasma Levels of Apoliporptoein A1 in Malaria-Exposed Primigravidae Are Associated with Severe Anemia
por: Simpson, David C., et al.
Publicado: (2010)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Residual Antimalarials in Malaria Patients from Tanzania – Implications on Drug Efficacy Assessment and Spread of Parasite Resistance
por: Hodel, Eva Maria, et al.
Publicado: (2009)

Large differences in variability for genes associated with antimalarial drug resistance between samples from Tanzania and Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2014)

High Throughput Functional Assays of the Variant Antigen PfEMP1 Reveal a Single Domain in the 3D7 Plasmodium falciparum Genome that Binds ICAM1 with High Affinity and Is Targeted by Naturally Acquired Neutralizing Antibodies
por: Oleinikov, Andrew V., et al.
Publicado: (2009)

Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug
por: Mubyazi, Godfrey M, et al.
Publicado: (2005)

Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector
por: Amin, Abdinasir A, et al.
Publicado: (2005)

Maternal Malaria and Gravidity Interact to Modify Infant Susceptibility to Malaria
por: Mutabingwa, Theonest K, et al.
Publicado: (2005)

Cost-Effectiveness of Pre-Referral Antimalarial, Antibacterial, and Combined Rectal Formulations for Severe Febrile Illness
por: Buchanan, James, et al.
Publicado: (2010)

Treatment of Relapsing Malaria with Specific Antimalarial Drugs in Combination with Penicillin
por: Deshmukh, P. L.
Publicado: (1947)

A sustainable, efficient, and potentially cost-effective approach to the antimalarial drug candidate MMV688533
por: Kavthe, Rahul D., et al.
Publicado: (2023)

The impact of endemic and epidemic malaria on the risk of stillbirth in two areas of Tanzania with different malaria transmission patterns
por: Wort, Ulrika Uddenfeldt, et al.
Publicado: (2006)

The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania
por: Reyburn, Hugh, et al.
Publicado: (2006)

Predictors of antibiotics co-prescription with antimalarials for patients presenting with fever in rural Tanzania
por: Njozi, Mustafa, et al.
Publicado: (2013)

Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania
por: Malisa, Allen Lewis, et al.
Publicado: (2012)

Antimalarial drug resistance: An overview
por: Antony, Hiasindh Ashmi, et al.
Publicado: (2016)

Antimalarial drug and renal toxicity
por: Wiwanitkit, Viroj
Publicado: (2015)

Herbicidal properties of antimalarial drugs
por: Corral, Maxime G., et al.
Publicado: (2017)

The threat of antimalarial drug resistance
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016)

Ethics and Antimalarial Drug Resistance
por: Cheah, Phaik Yeong, et al.
Publicado: (2020)

Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery
por: Murithi, James M., et al.
Publicado: (2020)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Getting antimalarials on target: impact of national roll-out of malaria rapid diagnostic tests on health facility treatment in three regions of Tanzania
por: Bruxvoort, Katia, et al.
Publicado: (2013)

World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
por: Bacon, David J, et al.
Publicado: (2007)

Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania
por: Kabanywanyi, Abdunoor M, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_tm010357p69d0d5p291egrmhcs